Delivery Order SPE2DB22D1202-SPE2DB25FVKY7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $24,960.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 15, 2025, with performance of work occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count package). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a $57,770.08 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran...
- The Defense Logistics Agency awarded a $1,866.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, with an ultimate completion date of July 24, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This award involved no set-aside designation,...
- The Defense Logistics Agency awarded a $6,030.23 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price contract, which is a child order under a larger vehicle, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery order draws...
- The Defense Logistics Agency awarded a delivery order valued at $3,059.76 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) with a firm fixed price structure. This competitively awarded contract, executed on September 9, 2025, is not set-aside and designates Conshohocken, Pennsylvania as the place of performance. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract valued at $8,801.10. The order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,897.41 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $8,201.13. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $25,511.16 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 13, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKY7Delivery Order
The Defense Logistics Agency awarded a $48,680.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Multaq 400 mg tablets (60-count units). This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order specifies a completion date of September 11, 2025, with performance to be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, serves as a critical vendor for federal medical procurement through its DLA contract portfolio. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, and related medical commodities. This delivery order for Multaq, an antiarrhythmic medication, exemplifies AmerisourceBergen's role as a primary supplier of specialized pharmaceutical products to the Defense Health Agency and other federal healthcare systems through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.7k | 9/10/25 |